Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Other Non-Current Assets (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Other Non-Current Assets for 2 consecutive years, with $1.7 million as the latest value for Q2 2023.

  • On a quarterly basis, Other Non-Current Assets rose 99900.0% to $1.7 million in Q2 2023 year-over-year; TTM through Jun 2023 was $1.7 million, a 99900.0% increase, with the full-year FY2022 number at $1.7 million, changed N/A from a year prior.
  • Other Non-Current Assets was $1.7 million for Q2 2023 at LENZ Therapeutics, up from $1.7 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.7 million in Q1 2022 to a low of $1.7 in Q3 2022.